Search results for: 'engineering service'
- Related search terms
- service robots
- engineering labor market
- service+robots
- Engineering Plastics, Global, 2025–2032
- engineering plastics global 2025 2022
-
25 Jul 2024  |  Global  |  Technology Research
Engineered Antibody Therapeutics for Cancer
Technology advances and increasing interest from Tier I pharmaceuticals are driving the growth of engineered antibodies
This study analyzes the emergence of engineered antibody therapeutics for cancer, examining the factors driving their adoption. The limitations of monoclonal antibodies have led to an increasing demand for novel formats. Companies are developing multispecific antibodies, such as bispecifics and trispecifics, and antibody fragments, such as Fab and ...
$4,950.00 -
23 Jun 2023  |  Global  |  Market Research
Global Tissue-engineered Skin Substitute Growth Opportunities
Breakthrough Technologies and Competitive Intensity Drive Innovation
Rising incidents of burn injuries, road accidents, and other trauma injuries, along with increasing cases of chronic wounds, such as diabetic ulcers and venous ulcers, are boosting the global tissue-engineered skin substitutes (TESS) market. Moreover, the increasing number of surgical injuries, plastic surgeries, cosmetic surgeries, and other recon...
$4,950.00 -
02 Sep 2025  |  Global  |  Technology Research
Technological Advances in Engineered Cell Therapies, Global, 2025–2029
Emerging Trends and Technologies in Engineered Cell Therapies
Engineered cell therapies have become a revolutionary medical field, surpassing conventional methods such as systemic medications and prominent immunosuppression to provide long-lasting, programmable, and targeted treatments for complicated diseases. Recent technical developments in engineered cell therapies examine how the rapid growth of cell eng...
$4,950.00 -
21 Mar 2025  |  Global  |  Market Research
Pharmaceutical Clinical Contract Peripheral Services, Global, 2025–2030
The CRO Industry is Witnessing Transformational Growth Due to Industry Convergence and an Increasing Reliance on the Functional Service Provider (FSP) Model
As trial volumes normalize after the COVID-19 pandemic, pharma and biopharma companies are re-focusing on their drug development pipelines. As a result, the market has been creating an increasing number of clinical trial outsourcing opportunities for CROs, with these service providers also refining their processes to ensure better clinical trial tu...
$4,950.00 -
23 Jan 2026  |  Global  |  Technology Research
Next-Generation Therapeutic Platforms: AI-Enabled Drug Discovery, Small molecules, Deep Proteomics, RNA Engineering, and Targeted Immunomodulation
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) delivers provides strategic insights into breakthrough innovations shaping the future of healthcare, life sciences, and precision therapeutics. It highlights advances in AI-enabled diagnostics, metabolic reprogramming, small molecules, deep proteomics, RNA disco...
$950.00 -
18 Dec 2023  |  North America  |  Market Research
Global Medical Technology (MedTech) Managed Vendor Services Market, Forecast to 2028
Disruption of Conventional Services Transforms Healthcare Systems and Creates New Growth Opportunities
Frost & Sullivan expects the global MedTech managed vendor services market to witness significant changes over the next few years, driven by the increasing technology adoption by managed equipment services (MES), multi-vendor services (MVS), and professional service providers. They will do so due to the transformations in healthcare facilities, the...
$4,950.00 -
19 Jun 2026  |  Global  |  Technology Research
Innovations and Growth Opportunities in AI-Driven Drug Discovery, Protein Engineering, Genomic Diagnostics, Advanced Drug Delivery, and Precision Medicine
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping drug discovery, diagnostics, and therapeutic delivery across oncology, infectious diseases, rare and metabolic disorders, neuromuscular and neurodegenerative conditions, diabetes, ophthalmol...
$950.00 -
23 Aug 2022  |  North America  |  Market Research
Global Bioanalytical Testing Services, 2021–2027
Acquisition of Disruptive Technologies will be the Key to Driving Growth
As the pharma market recovers from the debilitating impact of COVID-19 on the drug discovery and development pipelines, there is an increasing requirement for outsourcing services in the form of contract research organizations (CROs) and contract development & manufacturing organizations (CDMOs), which is likely to drive the already strong drug dev...
$4,950.00 -
22 Aug 2013  |  North America  |  Technology Research
Advances in Tissue Engineering and Organ Regeneration (Technical Insights)
State-of-the-Art Technology for Artificial Organ Implant
Tissue engineering, which is now being categorized as a form of regenerative medicine, can be defined as biomedical engineering to reconstruct, repair, and improve biological tissues. Research efforts in tissue engineering have been ongoing and it is emerging as one of the key areas of medical research. Furthermore, there are vast developments in t...
$4,950.00 -
17 Jan 2025  |  Global  |  Technology Research
Emerging Technology Innovations in Immune-oncology, Precision Medicine and Cell Engineering
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across recent innovations cross immunotherapies, precision medicine, cancer treatment, cell engineering, liquid biopsy and AI-enabled drug discovery and development. The TOE also highlights recent advances in implantables, ophthalmology, neurop...
$950.00